Next Article in Journal
Chelerythrine-Induced Apoptotic Cell Death in HepG2 Cells Involves the Inhibition of Akt Pathway and the Activation of Oxidative Stress and Mitochondrial Apoptotic Pathway
Next Article in Special Issue
Peroxisome Proliferator-Activated Receptor α Attenuates Hypertensive Vascular Remodeling by Protecting Vascular Smooth Muscle Cells from Angiotensin II-Induced ROS Production
Previous Article in Journal
Neuropharmacological Effects of Terpenoids on Preclinical Animal Models of Psychiatric Disorders: A Review
Previous Article in Special Issue
Muscone and (+)-Borneol Cooperatively Strengthen CREB Induction of Claudin 5 in IL-1β-Induced Endothelium Injury
 
 
Article
Peer-Review Record

Natural Activators of Autophagy Increase Maximal Walking Distance and Reduce Oxidative Stress in Patients with Peripheral Artery Disease: A Pilot Study

Antioxidants 2022, 11(9), 1836; https://doi.org/10.3390/antiox11091836
by Ombretta Martinelli 1,†, Mariangela Peruzzi 2,3,†, Simona Bartimoccia 2, Alessandra D’Amico 4, Simona Marchitti 5, Speranza Rubattu 5,6, Giovanni Alfonso Chiariello 7, Luca D’Ambrosio 8, Sonia Schiavon 8, Fabio Miraldi 2, Wael Saade 2, Mizar D’Abramo 2, Annachiara Pingitore 1, Lorenzo Loffredo 2, Cristina Nocella 2, Maurizio Forte 5,*,‡ and Pasquale Pignatelli 2,3,‡
Reviewer 1:
Antioxidants 2022, 11(9), 1836; https://doi.org/10.3390/antiox11091836
Submission received: 29 July 2022 / Revised: 2 September 2022 / Accepted: 14 September 2022 / Published: 18 September 2022
(This article belongs to the Special Issue Oxidative Stress in Vascular Regulation, Disease and Treatment)

Round 1

Reviewer 1 Report

This study investigated the effects of treatment with a mixture of trehalose, spermidine, nicotinamide and polyphenols patients with PAD.  The primary outcome measured was performance in the 6-minute walk. Measures of oxidant stress and autophagy were also reported.  Some minor issues with reporting of methods and data presentation should be addressed.

 

Although another paper has been published, could more details of the FMD measurements be included in the methods?  Was this FMD in the brachial artery or the popliteal artery?

 

Could the data presented in Table 2 be expanded and separated into patients given the mixture and patients who did not receive treatment?  Could heart rate at rest and following the 6MWT be presented for before and after the treatment period be included?  Similarly, could resting blood pressure before and after the treatment period be included?

 

In the figure legends, please provide separate “n” values for the no treatment and mixture groups.

 

In figures 2 and 3, what do the question mark symbols “?” represent?

 

Line 302 on page 9: What is Knox?

 

Line 373 on page 10:  It seems as if a word might be missing after “disease related”.

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Reviewer 2 Report

see enclosed word-file

Comments for author File: Comments.docx

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Back to TopTop